Please note that this was recorded in 2016. All AMPEDTM content is reviewed and approved annually by the Training & Education Committee as relevant and accurate, but new data may now be available and new studies may have since been published.
AMP Education is constantly updating these educational offerings, so keep checking back at educate.amp.org for new content, content updates, and information on cutting-edge molecular pathology research and applications.
This collection will give you access to the recordings of the presentations (listed below). CME/CMLE or SAM is not available for this collection
This Award for Excellence talk discusses the foundations for discovering the genetic basis of common human diseases including the early development of theoretical methods for mapping the genes underlying polygenic traits; sequencing of the human genome comprehensive discovery of the genetic variation in the human population; systematic characterization of genomic features; and empirical insights into the genetic architecture of common human disease. It describes recent progress in genetic analysis of important diseases such as schizophrenia, heart disease, inflammatory bowel disease and obesity and close by looking forward to the years ahead.
Learning Objectives:
- Recognize the history of discovering the genetic basis of human diseases.
- Analyze the characterization of genetic variation and genomic features.
- Conclude that progress in genomic medicine will be based on emerging discoveries.
Speaker: Eric S. Lander, PhD, Broad Institute of Harvard and MIT, Cambridge, MA, USA
Duration: 1.25 hr
Recording Date: November 10, 2016
Note: Join the AMP Family for discounted access to the most current educational resources!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
